EMMAUS LIFE SCIENCES, INC. (EMMA) Free cash flow 2016–2025
EMMAUS LIFE SCIENCES, INC. (EMMA) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$12,000FY2025 · since FY2016: -$3.0M → -$12,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$12,000 | +99.5% |
| FY2024 | -$2.3M | -51.2% |
| FY2023 | -$1.5M | +70.2% |
| FY2022 | -$5.1M | -284.3% |
| FY2021 | -$1.3M | +46.2% |
| FY2020 | -$2.5M | +46.2% |
| FY2019 | -$4.6M | +20.0% |
| FY2018 | -$5.7M | -16.4% |
| FY2017 | -$4.9M | -65.0% |
| FY2016 | -$3.0M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice